Company intelligence / Profile preview

Postbiotica

Lodi, Lombardy, Italy
Ownership
Private
Employees
~15
Development stage
Other
01

Overview

Postbiotica is an Italian biotechnology company specializing in the development and production of postbiotics, which are bioactive compounds generated during the fermentation of microorganisms. Utilizing its proprietary PB-Tech platform, the company creates standardized, non-living microbial derivatives that offer therapeutic benefits without the stability and safety issues often associated with live probiotics. Postbiotica's portfolio primarily targets the skincare and nutraceutical markets, focusing on applications for skin health, immune modulation, and gut wellness. The company operates as a spin-off from Humanitas University and collaborates with industrial partners to integrate its postbiotic ingredients into consumer products and therapeutic formulations.

Therapeutic areas
ImmunologyDermatologyGastroenterology
Modalities
Microbial therapyBiologicPeptides
Industry
Biotech
02

Drug pipeline

6 assets

PoZibio

Preclinical

5 more assets in the full pipeline.

Request access →
03

Partnerships

Humanitas University

Beyond the preview

Go deeper on Postbiotica.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Postbiotica.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call